The Use of Antibiotics in COVID-19 Infections

Dear Colleagues,

A recent report on the casualties related to antibiotic resistance by the World Health Organization (WHO) identified an alarming rate of 700,000 lives per year at present and predicts a disturbing 10 million/year by 2050, ensuring that antibiotic resistance will be the most prevalent cause of death. Adding to this, the WHO also forewarns the severity of antibiotic resistance, stating that “it threatens the achievements of modern medicine, a post-antibiotic era—in which common infections and minor injuries can kill—is a very real possibility for the 21st century”.

Overuse or misuse of antibiotics recommended by physicians/self-medication at the time of infection have meant that drug-resistant pathogens become a major health care issue with millions of reported cases every year. With a pandemic such as COVID-19, the overuse of antibiotics can represent a critical point in fighting antimicrobial resistance. The unnecessary use of antibiotics can facilitate the spread of resistant pathogens, and the use of antibiotics in the management of a viral disease such as COVID-19 could have heavy implications for antimicrobial resistance response.

Therefore, this Special Issue aims to include studies on the use of antimicrobial therapy approaches in COVID-19 patients.

Dr. Eleonora Nicolai
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.